htn_acei_med htn_arb_med
Name
htn_alpha_med
Label
Alpha Blocker: Self-reported use
Description

Self-reported drugs at PSG visit, open text then grouped according to effect

Domain
takingornot
  • 0: Not taking
  • 1: Taking
Type
choices
Alpha Blocker: Self-reported use vs Study visit number
Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 Incident Outcomes Tracking
Total 1,123 758 566 121 2 -
Not taking 1,080 733 547 112 2 -
Taking 43 25 19 9 - -
Alpha Blocker: Self-reported use vs Sex of the participant
Visit 1
Male Female Total
Total 608 515 1,123
Not taking 572 508 1,080
Taking 36 7 43
Alpha Blocker: Self-reported use vs Sex of the participant
Visit 2
Male Female Total
Total 406 352 758
Not taking 386 347 733
Taking 20 5 25
Alpha Blocker: Self-reported use vs Sex of the participant
Visit 3
Male Female Total
Total 304 262 566
Not taking 287 260 547
Taking 17 2 19
Alpha Blocker: Self-reported use vs Sex of the participant
Visit 4
Male Female Total
Total 67 54 121
Not taking 59 53 112
Taking 8 1 9
Alpha Blocker: Self-reported use vs Sex of the participant
Visit 5
Male Female Total
Total - 2 2
Not taking - 2 2
Taking - - -
Alpha Blocker: Self-reported use vs Race of the participant
Visit 1
Asian Black Hispanic Native American White Total
Total 12 23 13 10 1,065 1,123
Not taking 12 19 13 10 1,026 1,080
Taking - 4 - - 39 43
Alpha Blocker: Self-reported use vs Race of the participant
Visit 2
Asian Black Hispanic Native American White Total
Total 4 8 6 6 734 758
Not taking 4 7 6 6 710 733
Taking - 1 - - 24 25
Alpha Blocker: Self-reported use vs Race of the participant
Visit 3
Asian Black Hispanic Native American White Total
Total 4 4 5 4 549 566
Not taking 4 4 5 4 530 547
Taking - - - - 19 19
Alpha Blocker: Self-reported use vs Race of the participant
Visit 4
Asian Black Hispanic Native American White Total
Total 3 1 2 2 113 121
Not taking 3 - 2 2 105 112
Taking - 1 - - 8 9
Alpha Blocker: Self-reported use vs Race of the participant
Visit 5
Asian Black Hispanic Native American White Total
Total - - - - 2 2
Not taking - - - - 2 2
Taking - - - - - -